Deep brain stimulation for treatment-resistant depression: a safe and effective option

Area of Science:

• Neuroscience
• Psychiatry
• Neurosurgery

Background:

• Major depressive disorder (MDD) is a leading cause of global disability.
• Approximately 30% of MDD patients do not respond adequately to conventional treatments, leading to persistent symptoms and relapse.
• Deep brain stimulation (DBS) is an emerging therapeutic strategy for treatment-resistant depression (TRD).

Purpose of the Study:

• To review existing literature on the pathophysiological mechanisms of depression.
• To evaluate the role of DBS as a therapeutic option for TRD patients.
• To explore potential future directions for DBS in depression treatment.

Main Methods:

• Review of randomized controlled trials (RCTs) and open-label studies.
• Analysis of neurophysiological mechanisms underlying DBS in MDD.
• Investigation of various DBS target locations for depression.

Main Results:

• Depression is a complex systems-level disorder involving interconnected brain structures and neural networks.
• Subcallosal cingulate gyrus (SCG) and ventral capsule/ventral striatum (VC/VS) are identified as key targets for DBS in TRD.
• DBS demonstrates the capacity to modulate neural activity in relevant brain regions.

Conclusions:

• DBS is a viable therapeutic option for TRD.
• Further research into DBS targets and techniques, such as directional leads, is warranted.
• DBS holds potential to become a first-line treatment for TRD in the future.